THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Sheeja Aravindan to Cell Line, Tumor

This is a "connection" page, showing publications Sheeja Aravindan has written about Cell Line, Tumor.
Connection Strength

0.785
  1. Targeting acquired oncogenic burden in resilient pancreatic cancer: a novel benefit from marine polyphenols. Mol Cell Biochem. 2019 Oct; 460(1-2):175-193.
    View in: PubMed
    Score: 0.122
  2. Hormophysa triquerta polyphenol, an elixir that deters CXCR4- and COX2-dependent dissemination destiny of treatment-resistant pancreatic cancer cells. Oncotarget. 2017 Jan 24; 8(4):5717-5734.
    View in: PubMed
    Score: 0.103
  3. Polyphenols from marine brown algae target radiotherapy-coordinated EMT and stemness-maintenance in residual pancreatic cancer. Stem Cell Res Ther. 2015 Sep 22; 6:182.
    View in: PubMed
    Score: 0.094
  4. Novel adjuvants from seaweed impede autophagy signaling in therapy-resistant residual pancreatic cancer. J Biomed Sci. 2015 Apr 17; 22:28.
    View in: PubMed
    Score: 0.091
  5. Novel synthetic monoketone transmute radiation-triggered NF?B-dependent TNFa cross-signaling feedback maintained NF?B and favors neuroblastoma regression. PLoS One. 2013; 8(8):e72464.
    View in: PubMed
    Score: 0.081
  6. Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algae. PLoS One. 2013; 8(4):e61977.
    View in: PubMed
    Score: 0.079
  7. Radiation-induced TNFa cross signaling-dependent nuclear import of NF?B favors metastasis in neuroblastoma. Clin Exp Metastasis. 2013 Aug; 30(6):807-17.
    View in: PubMed
    Score: 0.079
  8. De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution. Sci Rep. 2019 08 13; 9(1):11766.
    View in: PubMed
    Score: 0.031
  9. RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes. Oncotarget. 2015 Nov 03; 6(34):36522-34.
    View in: PubMed
    Score: 0.024
  10. Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes. BMC Cancer. 2015 Jul 10; 15:514.
    View in: PubMed
    Score: 0.023
  11. Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells. BMC Genomics. 2015 Jul 07; 16:501.
    View in: PubMed
    Score: 0.023
  12. Irreversible EGFR inhibitor EKB-569 targets low-LET ?-radiation-triggered rel orchestration and potentiates cell death in squamous cell carcinoma. PLoS One. 2011; 6(12):e29705.
    View in: PubMed
    Score: 0.018
  13. Radiation-triggered tumor necrosis factor (TNF) alpha-NFkappaB cross-signaling favors survival advantage in human neuroblastoma cells. J Biol Chem. 2011 Jun 17; 286(24):21588-600.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES